Both genetic (by siRNA) and pharmacological (by AOAA) inhibition of CBS in the SMMC-7721 HCC cell line with reduced H2S production decreased cell viability and enhanced ROS production in vitro. This evidence concerns the gene CBS and hepatocellular carcinoma.